4
Changes in Ownership
Coherus Oncology, Inc. Filed Acc 0001567619-20-020095
Chief Financial Officer sold 1,995 shares at $17.49 ($34,896)
- Chief Financial Officer acquired 1,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Viret Jean-Frederic · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-11-17 | Sale : show line 1 in the form | −1,995 | $17.49 | $34,896 | 38,769 | D |
| 2020-11-17 | Exercise or conversion : show line 2 in the form | +1,500 | $13.50 | $20,250 | 40,269 | D |
| Open-market sales · 1,995 sh · avg $17.49 · $34,896 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-11-17 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −1,500 | 110,241 | D |
Loading xslF345X03/doc1.xml…